In-Depth

See all
See All News
Search News
Sign Up for Our Newsletter

Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD.

Conference Coverage
See all
Around the Web
See all
Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt
Large randomized, sham-controlled trial evaluates interatrial shunting in a heart failure population currently without effective treatment
Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction
Abre™ Venous Self-Expanding Stent System Safe, Effective in Treating ChallengingDeep
Venous Lesions
CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI
The novel non-DES, non-BMS COBRA PzF NanoCoated Coronary Stent (NCS) with just 14-days DAPT demonstrated statistically less bleeding (BARC 1-5) compared to the DES arm at 3 or 6 months DAPT post-PCI, low 0.6% ST and low 3.7% ischemic-driven TLR at 6 months.